Examination about the change of the cerebral blood flow before and after the treatment of the abstinence supplement using the cerebral blood flow scintigraphy

Examination about the change of the cerebral blood flow before and after the treatment of the abstinence supplement using the cerebral blood flow scintigraphy - Examination about the change of the cerebral blood flow for the treatment of the abstinence supplement

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011144

Enrollment

Registered

2013-08-01

Start date

2013-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcoholism

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: We intend for the patients who consulted Kotani clinic for alcoholism. They receive abstinence from alcoholic drinks treatment (including psycho-social therapy and rehabilitation such as the counseling), and we selects the patients who became the alcohol abstinence possible. We give regtect in Kotani clinic subsequently. We intend for the patients who secession from alcohol dependence is done and can continue abstinence from alcoholic drinks.

Exclusion criteria

Exclusion criteria: The patients who drank again during abstinence from alcoholic drinks treatment. The patients who stopped going to hospital and treatment by oneself. The patients who were not able to undergo cerebral blood flow scintigraphy.

Design outcomes

Primary

Measure	Time frame
In this study, we intend for the patients who consulted an alcohol dependence treatment outpatient. We intend for the patients with the abstinence will. We use Regtect as abstinence adjuvant medicine. Treatment using Regtect is provided. We conduct a cognitive function evaluation and foreign follow-up before and after treatment. The cerebral blood flow scintigraphy is carried out in a hospital nuclear medicine laboratory attached to the Osaka City University School of Medicine.	—

Measure

Time frame

In this study, we intend for the patients who consulted an alcohol dependence treatment outpatient. We intend for the patients with the abstinence will. We use Regtect as abstinence adjuvant medicine. Treatment using Regtect is provided. We conduct a cognitive function evaluation and foreign follow-up before and after treatment. The cerebral blood flow scintigraphy is carried out in a hospital nuclear medicine laboratory attached to the Osaka City University School of Medicine.

—

Countries

Japan

Contacts

Public ContactShigeaki Higashiyama

Osaka City University, Graduate School of Medicine Nuclear Medicine

higashiya@med.osaka-cu.ac.jp06-6645-3885

Outcome results